Cite
HARVARD Citation
Simon, M. et al. (2022). An open‐label, dose‐escalation study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of single doses of GSK2586881 in participants with pulmonary arterial hypertension. Pulmonary circulation. p. n/a. [Online].